Siirry transaktioihin
Terveydenhuolto

Protalix BioTherapeutics, Inc. has completed a private stock placement

Protalix BioTherapeutics, Inc. has raised funds to refinance the company for further development.

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received the approval of the US Food and Drug Administration, for the treatment of Gaucher disease.

Oaklins’ team in Israel advised Protalix BioTherapeutics, Inc. and acted as a member in the distributors’ consortium.

Palvelut
Rahoitus, velkaneuvonta & pääomamarkkinat
Osapuolet

Ota yhteyttä transaktiotiimiin

 Ruben  Eblagon

Ruben Eblagon

Principal

Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner

Tel Aviv, Israel
Oaklins Rosario
 Olga  Geyber

Olga Geyber

Support

Tel Aviv, Israel
Oaklins Rosario

Transaktiot

Navitas Petroleum has issued bonds worth US$117 million
Energia

Navitas Petroleum has issued bonds worth US$117 million

Navitas Petroleum has completed a fundraising to to refinance and develop the company.

Lue lisää
Laptaria cu Caimac has raised growth capital
Maatalous | Elintarvikkeet

Laptaria cu Caimac has raised growth capital

Laptaria cu Caimac has raised US$3.5 million via a corporate bond private placement that has attracted strong interest both from high-net-worth individuals and institutional investors.

Lue lisää
Global Media Santé has been acquired by SFP Expansion
Pääomasijoittaminen | Terveydenhuolto | TMT

Global Media Santé has been acquired by SFP Expansion

Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Lue lisää